Health and Medicine

Expert faculty will provide up-to-date education on multifaceted care for patients presenting with myocardial infarction, heart failure, cardiac rhythm disorders, and shock along with appropriate imaging, monitoring, and medical management. Special attention will be given to limiting complications in the cardiovascular care units for best-practice principles. The program will have didactic lectures integrated with challenging case discussions to highlight this rapidly growing field of medicine and a novel break-out session addressing optimal team dynamics in resuscitation. LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: -Review topics pertinent to the care of critically ill patients with cardiac…

With the EMA's guidance on the use of real world evidence in its regulatory decision-making, and federated learning networks that continue to support pharma, the integration of real world evidence into clinical research is transforming drug development. Following on from the 11th IMPACCT Real World Evidence Summit US, created-by biopharma-for biopharma, the IMPACCT Real World Evidence Summit Europe stands out as the only European industry-led meeting dedicated to the practical applications of real world evidence across all stages of clinical research from patient identification through to phase IV that will empower you to revolutionise your clinical research capabilities. Coming to…

The 7th Antigen-Specific Immune Tolerance Drug Development Summit returns as the definitive, industry-dedicated forum bringing you the latest discoveries, preclinical, proof-of-concept, biomarker, and clinical development on tolerogenic therapies. Immune tolerance approaches have unprecedented potential to not only treat autoimmune diseases but to cure them; resetting the immune system is the most advantageous approach in biopharma's arsenal to trailblaze past standard immunosuppression treatments and create a new era of transformative therapies. With Diamyd's phase III trial for type I diabetes, COUR, Anokion, Imcyse, Takeda, and Selecta's phase II trials all underway, the field is on the precipice of advancing efficacious antigen-specific…

Please join us at for our annual Swedish IBD update on Friday, June 1st, 2024! The annual Swedish Providence Update in Inflammatory Bowel Disease course will review new and forthcoming medical and surgical therapeutic approaches in IBD and its associated manifestations, as well their impact on the current management of these conditions. The therapeutic landscape in IBD continues to evolve, resulting in rapid and dramatic changes to therapeutic algorithms and disease monitoring. The course will review the impact of positioning new therapeutics, optimization of medical therapy, disease management in the perioperative period, extraintestinal manifestations, dietary, nonpharmacologic therapies and multi-disciplinary approaches…

Not that much time has passed since our last summit. But a lot has changed. From 2023 to 2024, the industry has made unequivocal advances, from tangible progress using artificial intelligence to robust biomarker development, permitting precise prognosis, astute stratification, and meticulous patient monitoring. Unsurprisingly, this is reflected by countless recent approvals, IND filings, and new companies emerging out of stealth-mode. In this context, the Precision Medicine in Inflammatory Bowel Disease Summit is returning for the second year, as the most comprehensive, ultra-specialized meeting. Uniting over 100 precision medicine in IBD experts, this summit will explore mind-blowing development that will…

Driving Innovation in Discovery and Chemistry, Validating Clinical Proof-of Concept and Streamlining CMC of Conjugates with Novel Payloads and Formats Traditional ADCs have seen significant success in recent years, but still face many challenges, from limited payload capacities to significant toxicities. Given these limitations, drug developers are venturing beyond the conventional boundaries of conjugate drug design, by exploring novel payloads and targeting formats, with companies including VincerX Pharma, Dyne Therapeutics, and Orum Therapeutics currently awaiting clinical validation. Join 150+ of your peers to share learnings and collaborate on novel design concepts, key translational and clinical development challenges, and address challenging…

The UCSF Pediatric and Adult Spine Surgery Course is a three-and-a-half-day event emphasizing pioneering trends in pediatric and adult spinal surgery. This course is designed to be interactive with didactic lectures given by leaders in the spine community. Participants will review surgical principles and techniques in the treatment of complex spinal disorders. Expert lecturers will describe the state-of-the-art treatment for a variety of Pediatric and Adult Spinal Disorders. Interactive case presentations will allow learners to apply knowledge to improve decision-making for complex spine pathology. Prices: Physicians: USD 925.00, Allied Health Professionals: USD 825.00, Residents/Fellows: USD 825.00 Speakers: Lionel Metz, MD,…

This breast imaging course is designed for both the clinical radiologist who specializes in breast imaging and the radiologist who has general diagnostic clinical duties. A practical approach will be emphasized, providing an overview and update on clinically relevant topics in breast imaging. The course will highlight recent developments, with a strong focus on the use of multimodality imaging and intervention (mammography, ultrasound and MRI). Half-day morning sessions Sunday thru Friday, with a full-day off on Wednesday. Course will include didactic lectures, faculty panel Q and A, and challenging casers. Breast imaging modalities will include mammography, ultrasound, MRI, digital-mammography and…

This live course will include lectures, hands-on workshops, interactive question and answer sessions, that aim to provide an overview of pediatric musculoskeletal conditions and sports-related injuries that are commonly encountered by Primary Care Providers. This course aims to provide a comprehensive learning experience that will improve providers’ knowledge, skills, and competence in managing specific conditions. In addition, participants can look forward to learning about our multidisciplinary approach to managing pediatric musculoskeletal and sports-related conditions through evidence-based practices. Time: 8:00 AM - 5:00 PM Prices: Physicians: USD 599.00, Advanced Practice Providers (PA/NP) / Physical Therapists / Nurses / Orthotist: USD 399.00,…

Determining MoA and Satisfying Regulatory Requirements In the dynamic cell therapy landscape, the challenge of potency assay development looms large, as exemplified by clinical holds experienced by Mesoblast and Verve Therapeutics in recent years. With unclear licensing standards and the surge in cell therapy products advancing through phase development, linking mechanisms of action to potency assays scientifically has become a pressing concern. At the 3rd Cell Therapy Potency Assay Summit, we bring together over 120 analytical, quality control, and regulatory experts to address these pressing concerns. Our goal is to collaboratively design more effective potency assays that not only streamline…

Join us at 15th Annual Congress on Controversies in Ophthalmology (COPHy) which will be held on March 15-16, 2024 in the historic city of Athens, Greece. COPHy 2024 will continue to focus on the debates concerning controversial issues in ophthalmology, the core of the congress. Leading world experts will present two opposed approaches to controversial issues. Each topic presented will be followed by a live discussion of ophthalmologists experienced in the area being discussed. For more information, visit our website: https://cophy.comtecmed.com/ URLs: Tickets: https://go.evvnt.com/2062814-0?pid=154 Facebook: https://go.evvnt.com/2062814-2?pid=154 LinkedIn: https://go.evvnt.com/2062814-3?pid=154 Time: 7:30 AM - 7:30 PM Prices: Full participation: Physicians and Scientists:…

The program is packed with valuable insights for practitioners, equipping them with fresh knowledge and practical tools for their professional endeavors. We will delve into recent breakthroughs in vaccines, travel recommendations, treatments for prevalent infections, as well as HIV, STDs, and TB management. Additionally, we'll explore emerging diagnostic tests and strategies for their optimal application in clinical practice. Upon completion of this activity, participants should be able to: Learning Objectives: Demonstrate new strategies for treatment of common infections in an era of resistance Recognize the role for new vaccines to prevent illness and morbidity Recognize the role of private-public health…

Advance More Personalized Therapies for Rare and Common Kidney Diseases The surge of clinical breakthroughs in SGLT2s, GLP-1s and ERAs for CKD, significant advancements to strengthen proteinuria and GFR slope as surrogates for long-term outcomes, and a wave of promising new targets in development, has truly lit the fuse on decades of innovative kidney research. Bringing together 200+ biopharma stakeholders, from scientific research to clinical development and outcomes, across three days of concentrated discussion, the 6th CKD Drug Development Summit is the definitive forum for KOLs, industry experts, and regulators to concentrate kidney innovation onto the next generation of drug…

The Mayo Clinic Sleep Medicine Update course is conducted by Mayo Clinic sleep researchers and clinicians. This course reviews the latest advances in practice and research using case-based scenarios enriched with personal clinical experiences. The course is designed to provide attendees with a comprehensive review of sleep disorders and practical steps to enhance clinical skills and practice. Relevant for sleep medicine specialists including MDs, DOs, nurse practitioners and physician assistants, internists and family medicine specialists, pediatric sleep medicine practitioners and general pediatricians, ENT specialists with interest in sleep apnea, psychiatrists with interest in insomnia, neurologists with interest in sleep associated…

GPCRs-targeted drug discovery continues to gain exponential momentum, with advances in screening tools, characterization of dynamic confirmations and basic GPCR biology, including orphan receptors. Coupled with numerous strategic collaboration and investment, the GPCR field is fuelling for the clinical progression of next-generation small molecules and biologics across a spectrum of indications and previously undrugged GPCR targets. Owing to this, the Annual GPCRs-Targeted Drug Discovery Summit returns for its 3rd year as the world's only and most comprehensive industry dedicated GPCR forum. Bringing two brand new specialized tracks of content (Target ID and Validation and Hit ID and Optimization), don't miss…

This interactive 30-hour course provides an introduction to single-use systems (SUS) in the biopharmaceutical industry, covering methods, requirements, and emerging trends in licensed biopharmaceutical therapeutics. Participants will gain a solid understanding of current good manufacturing practice (cGMP) guidelines, SUS application, and different types of SUS. The course will explore the fundamentals of biopharmaceutical production and provide attendees with the knowledge necessary to produce human therapeutics.

This forthcoming conference follows the success of the past eleven AAVM conferences held in Helsinki, Ottawa, Orlando, Prague, Tel Aviv, Washington DC, Berlin, Budapest, Rome and Madrid, as well as one held online during the COVID lockdown period. Antimicrobials are still critically important and necessary in farm and companion animal therapy, notwithstanding the increased attention and measures to promote an overall reduced and responsible use. The risk for the spread of bacterial resistance when antimicrobials are used is well known, and the interconnection of use of animal and human antimicrobials further increases the concern for human and animal health. Alternatives…

Antibody-drug conjugates are coming of age with a remarkable surge in recent times, which has marked a turning point in their development. Notable achievements include the ground-shaking triumph of ENHERTU, eye-popping investments like Pfizer's monumental $43 billion acquisition of Seagen, and the FDA's greenlight for ELAHERE. These milestones have transformed the ADC landscape, driving increased interest and investment in the field, which now has a preclinical and clinical arena dynamically evolving. As such, the 14th World ADC London returns next March. This will be the first opportunity in the new year to explore these monumental wins, reflect on ongoing challenges,…

Gain knowledge on the latest recommendations involving medical specialties important to the urgent care setting that can be immediately applied into practice. Mayo Clinic's Urgent Care Updates course is designed for the acute/urgent care provider and uses relevant lectures along with panel and roundtable discussions to provide opportunities to interact with faculty. URL: Tickets: https://go.evvnt.com/2051772-0?pid=154 Prices: MD/PHD: USD 950.00, Allied Health, NP, PA, Nurse, Retiree: USD 825.00 Category: Conferences | Science, Health and Medicine | CME (Continuing Medical Education) Date and Time: 25th April 2024 at 6:30 am to 12:05 pm

With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe's leading microbiome organisations are paving the way for drug development! Join us at the 8th Microbiome Movement- Drug Development Summit Europe where we will cover the most exciting progress in the microbiome world, from expanded analytics and larger-scale manufacturing to the most pressing challenges from translation to regulations. In January, 150+ microbiome innovators will be united in Barcelona for the flagship meeting for European microbiome-based therapeutic developers. We are bringing together microbiome trailblazers across industry, academia and investors to share their insights across autoimmune disorders,…